Insulin: A Growth Hormone and Potential Oncogene.
Diabetes mellitus
Growth
Hyperinsulinemia
Hypoinsulinemia
IGF-I
Insulin
Malignancy
Journal
Pediatric endocrinology reviews : PER
ISSN: 1565-4753
Titre abrégé: Pediatr Endocrinol Rev
Pays: Israel
ID NLM: 101202124
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
entrez:
26
3
2020
pubmed:
26
3
2020
medline:
6
5
2020
Statut:
ppublish
Résumé
Both in vitro and in vivo experimental studies proved that insulin has an important anabolic role. This physiological function of insulin is reflected in its well documented involvement in protein metabolism and in acceleration of cell proliferation. Support for a growth promoting action of insulin is further provided by clinical studies that revealed that children with hypoinsulinemia have a decreased growth rate whereas, on the other hand, children with hyperinsulinemia have an accelerated growth. While it was initially assumed that the growth activities of insulin are facilitated via cross-talk with the closely related insulin-like growth factor-1 receptor (IGF-1R), it is now clear that the vast majority of these activities are mediated via direct interaction with the insulin receptor (IR). The present article provides an overview of the growth and proliferative actions of insulin, with an emphasis on a number of pathological conditions, including cancer.
Identifiants
pubmed: 32208563
doi: 10.17458/per.vol17.2020.lw.insulinghpotentialoncogene
doi:
Substances chimiques
Insulin
0
Human Growth Hormone
12629-01-5
Insulin-Like Growth Factor I
67763-96-6
Growth Hormone
9002-72-6
Receptor, IGF Type 1
EC 2.7.10.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
191-197Informations de copyright
Copyright© of YS Medical Media ltd.